Advertisement

Japanese Journal of Radiology

, Volume 37, Issue 12, pp 832–840 | Cite as

Renal pelvic and ureteral wall thickening in renal cell carcinoma: prevalence, cause, and clinical significance

  • Kotaro Yoshida
  • Mami Hamaoka
  • Satoshi KobayashiEmail author
  • Junichi Matsumoto
  • Dai Inoue
  • Norihide Yoneda
  • Toshifumi Gabata
Original Article
  • 65 Downloads

Abstract

Purpose

This study was performed to characterize renal pelvic and ureteral wall thickening (PUWT) in renal cell carcinoma (RCC) patients, including prevalence, cause, and detailed radiological findings based on contrast-enhanced CT, and to correlate these features with corresponding pathological findings.

Materials and methods

152 patients pathologically diagnosed with RCC by surgery were included. Two radiologists retrospectively evaluated the presence of PUWT and the radiological characteristics based on CT. Relationships among clinical characteristics, CT findings, and PUWT were evaluated. Pathological findings of PUWT were also investigated.

Results

The prevalence of RCC-related PUWT was 10% (N = 15). PUWT was frequently observed in cases with advanced TNM stage. Tumor thrombus, sinus extent, and peritumoral neovascularity were significantly more frequent in cases with PUWT. PUWT was observed at the pelvis or from the pelvis to the upper ureter. Fourteen of 15 cases in which the pelvic/ureteral wall was pathologically investigated did not show any pathological abnormalities.

Conclusion

The prevalence of PUWT was 10% and most cases were thought to be caused by temporary vascular dilatation in the pelvis and ureter, which is a secondary condition caused by hypervascular RCC, and not a direct result of tumor invasion.

Keywords

Renal pelvic wall thickening Ureteral wall thickening Renal cell carcinoma CT 

Abbreviations

RCC

Renal cell carcinoma

UCSI

Urinary collecting system invasion

PUWT

Renal pelvic and ureteral wall thickening

Notes

Acknowledgements

We would like to thank Dr. Masaru Obokata for his statistical support.

Compliance with ethical standards

Conflict of interest

None of the authors have any relevant conflict of interest or industry support related to this project.

Ethical statement

This study had institutional review board approval and informed consent was waived.

References

  1. 1.
    Vikram R, Beland MD, MD, Blaufox CC, Moreno JL, Gore HJ, Harvin ME et al. ACR appropriateness criteria renal cell carcinoma staging. J Am Coll Radiol. 2016;3(5):518–25.CrossRefGoogle Scholar
  2. 2.
    Hallscheidt PJ, Bock M, Riedasch G, Zuna I, Schoenberg SO, Autschbach F, et al. Diagnostic accuracy of staging renal cell carcinomas using multidetector-row computed tomography and magnetic resonance imaging: a prospective study with histopathologic correlation. J Comput Assist Tomogr. 2004;28(3):333–9.CrossRefGoogle Scholar
  3. 3.
    Froemming A, Potretzke T, Takahashi N, Kim B. Upper tract urothelial cancer. Eur J Radiol. 2018;98:50–60.CrossRefGoogle Scholar
  4. 4.
    Takahashi N, Kawashima A, Glockner JF, Hartman RP, Kim B, King BF. MR urography for suspected upper tract urothelial carcinoma. Eur Radiol. 2009;19(4):912–23.CrossRefGoogle Scholar
  5. 5.
    Gayer G, Desser TS, Hertz M, Osadchy A, Daniel BL, Zissin R. Spontaneous suburothelial hemorrhage in coagulopathic patients: CT diagnosis. AJR Am J Roentgenol. 2011;197(5):W887–W89090.CrossRefGoogle Scholar
  6. 6.
    Anderson CB, Clark PE, Morgan TM, Stratton KL, Herrell SD, Davis R, et al. Urinary collecting system invasion is a predictor for overall and disease-specific survival in locally invasive renal cell carcinoma. Urology. 2011;78(1):99–104.CrossRefGoogle Scholar
  7. 7.
    Verhoest G, Avakian R, Bensalah K, Thuret R, Ficarra V, Artibani W, et al. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma. J Urol. 2009;182(3):854–9.CrossRefGoogle Scholar
  8. 8.
    Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345(23):1655–9.CrossRefGoogle Scholar
  9. 9.
    Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R, European Organisation for R, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet. 2001;358(9286):966–70.CrossRefGoogle Scholar
  10. 10.
    Pearson JC, Tanagho EA, Palubinskas AJ. Nonoperative diagnosis of pyelocalyceal deformity due to venous impressions. Urology. 1979;13(2):207–10.CrossRefGoogle Scholar
  11. 11.
    Beckmann CF, Abrams HL. Idiopathic renal vein varices: incidence and significance. Radiology. 1982;143(3):649–52.CrossRefGoogle Scholar
  12. 12.
    Camuzzi FA, Kleinman SZ, Politano VA. Ureteral varices. Urology. 1980;15(6):588–9.CrossRefGoogle Scholar
  13. 13.
    Karlo CA, Di Paolo PL, Hricak H, Tickoo SK, Russo P, Akin O. CT of renal cell carcinoma: assessment of collecting system invasion. AJR Am J Roentgenol. 2013;201(6):W821–W827827.CrossRefGoogle Scholar

Copyright information

© Japan Radiological Society 2019

Authors and Affiliations

  1. 1.Department of RadiologyKanazawa University Graduate School of MedicineKanazawaJapan

Personalised recommendations